What is Mega Lifesciences PCL Intrinsic Value: Projected FCF?
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for Mega Lifesciences PCL's Intrinsic Value: Projected FCF or its related term are showing as below:
BKK:MEGA'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.78 Med: 1.73 Max: 4.73
Current: 0.78
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Mega Lifesciences PCL was 4.73. The lowest was 0.78. And the median was 1.73.
BKK:MEGA's Price-to-Projected-FCF is ranked better than 82.9% of 620
companies
in the Drug Manufacturers industry
Industry Median: 1.62
vs BKK:MEGA: 0.78
Mega Lifesciences PCL Intrinsic Value: Projected FCF Historical Data
The historical data trend for Mega Lifesciences PCL's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Mega Lifesciences PCL Intrinsic Value: Projected FCF Chart
Competitive Comparison of Mega Lifesciences PCL's Intrinsic Value: Projected FCF
For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mega Lifesciences PCL's Price-to-Projected-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Mega Lifesciences PCL's Price-to-Projected-FCF falls into.
Mega Lifesciences PCL Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mega Lifesciences PCL (BKK:MEGA) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Mega Lifesciences PCL's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
25.50
/
32.528877087887
=
0.78
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mega Lifesciences PCL Intrinsic Value: Projected FCF Related Terms
Thank you for viewing the detailed overview of Mega Lifesciences PCL's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BKK:MEGA has been successfully added to your 